80 results on '"Worek, Franz"'
Search Results
2. Development of a scintillation proximity assay for [3H]epibatidine binding sites of Tetronarce californica muscle-type nicotinic acetylcholine receptor
3. Identification of ligands binding to MB327-PAM-1, a binding pocket relevant for resensitization of nAChRs
4. Determination of tissue distribution of VX and its metabolites EMPA and EA-2192 in various rat tissues by LC-ESI-MS/MS after phosphotriesterase treatment
5. Synthesis and biological evaluation of novel MB327 analogs as resensitizers for desensitized nicotinic acetylcholine receptors after intoxication with nerve agents
6. The use of bispyridinium non-oxime analogues for the restoration of nerve agent impaired neuromuscular transmission in rat hemidiaphragms – Structure optimization
7. Inhibition kinetics of acetylcholinesterase and butyrylcholinesterase from various species by 2-(2-cresyl)-4H-1,3,2-benzodioxaphosphorin-2-oxide (CBDP)
8. Uncharged mono- and bisoximes: In search of a zwitterion to countermeasure organophosphorus intoxication
9. Suitability of human HepaRG cells and liver spheroids as in vitro model to investigate the bioactivation of the organothiophosphate pesticide parathion
10. Screening for new ligands of the MB327-PAM-1 binding site of the nicotinic acetylcholine receptor
11. Restoration of nerve agent impaired neuromuscular transmission in rat diaphragm by bispyridinium non-oximes – Structure-activity relationships
12. Toxicokinetic analysis of the highly toxic nerve agent VX in commercially available multi-organ-chips – Ways to overcome compound absorption
13. MS Binding Assays with UNC0642 as reporter ligand for the MB327 binding site of the nicotinic acetylcholine receptor
14. AChE reactivation in precision-cut lung slices following organophosphorus compound poisoning
15. The suitability of a polydimethylsiloxane-based (PDMS) microfluidic two compartment system for the toxicokinetic analysis of organophosphorus compounds
16. A pharmacologically pre-contracted smooth muscle bowel model for the study of highly-potent opioid receptor agonists and antagonists
17. A novel binding site in the nicotinic acetylcholine receptor for MB327 can explain its allosteric modulation relevant for organophosphorus-poisoning treatment
18. Inhibition of an organophosphate-detoxifying bacterial phosphotriesterase by albumin and plasma thiol components
19. Release of protein-bound nerve agents by excess fluoride from whole blood: GC-MS/MS method development, validation, and application to a real-life denatured blood sample
20. Impact of soman and acetylcholine on the effects of propofol in cultured cortical networks
21. A catalytic bioscavenger with improved stability and reduced susceptibility to oxidation for treatment of acute poisoning with neurotoxic organophosphorus compounds
22. Screening of chiral shift reagents suitable to generically separate the enantiomers of V-agents by 31P-NMR spectroscopy
23. Human small bowel as model for poisoning with organophosphorus compounds
24. Novel cysteine- and albumin-adduct biomarkers to prove human poisoning with the pesticide oxydemeton-S-methyl
25. Cytostatic resistance profile of the sulfur mustard resistant keratinocyte cell line HaCaT/SM
26. Counteracting desensitization of human α7-nicotinic acetylcholine receptors with bispyridinium compounds as an approach against organophosphorus poisoning
27. Electrophysiological investigation of the effect of structurally different bispyridinium non-oxime compounds on human α7-nicotinic acetylcholine receptor activity—An in vitro structure-activity analysis
28. Sulfur mustard resistant keratinocytes obtained elevated glutathione levels and other changes in the antioxidative defense mechanism
29. Human small bowel as a useful tool to investigate smooth muscle effects of potential therapeutics in organophosphate poisoning
30. Searching for putative binding sites of the bispyridinium compound MB327 in the nicotinic acetylcholine receptor
31. The oximes HI-6 and MMB-4 fail to reactivate soman-inhibited human and guinea pig AChE: A kinetic in vitro study
32. Effects of anti-inflammatory compounds on sulfur mustard injured cells: Recommendations and caveats suggested by in vitro cell culture models
33. Alteration of miRNA expression in a sulfur mustard resistant cell line
34. Development of a sensitive, generic and easy to use organophosphate skin disclosure kit
35. Precision cut lung slices as test system for candidate therapeutics in organophosphate poisoning
36. Blaptica dubia as sentinels for exposure to chemical warfare agents – a pilot study
37. Bispyridinium non-oximes: An evaluation of cardiac effects in isolated hearts and smooth muscle relaxing effects in jejunum
38. Reactivation of nerve agent-inhibited human acetylcholinesterase by obidoxime, HI-6 and obidoxime+HI-6: Kinetic in vitro study with simulated nerve agent toxicokinetics and oxime pharmacokinetics
39. Application of a dynamic in vitro model with real-time determination of acetylcholinesterase activity for the investigation of tabun analogues and oximes
40. Adaptation of a dynamic in vitro model with real-time determination of butyrylcholinesterase activity in the presence of cyclosarin and an oxime
41. Reactions of methylphosphonic difluoride with human acetylcholinesterase and oximes – Possible therapeutic implications
42. Post-exposure treatment of VX poisoned guinea pigs with the engineered phosphotriesterase mutant C23: A proof-of-concept study
43. Freeze-drying of HI-6-loaded recombinant human serum albumin nanoparticles for improved storage stability
44. In vitro toxicokinetic studies of cyclosarin: Molecular mechanisms of elimination
45. Effectiveness of a substituted β-cyclodextrin to prevent cyclosarin toxicity in vivo
46. Detoxification of alkyl methylphosphonofluoridates by an oxime-substituted β-cyclodextrin – An in vitro structure–activity study
47. Elimination pathways of cyclosarin (GF) mediated by β-cyclodextrin in vitro: Pharmacokinetic and toxicokinetic aspects
48. New modified β-cyclodextrin derivatives as detoxifying agents of chemical warfare agents (II). In vitro detoxification of cyclosarin (GF): General screening and toxicokinetic aspects of OP scavengers
49. New modified β-cyclodextrin derivatives as detoxifying agents of chemical warfare agents (I). Synthesis and preliminary screening: Evaluation of the detoxification using a half-quantitative enzymatic assay
50. Detoxification of tabun at physiological pH mediated by substituted β-cyclodextrin and glucose derivatives containing oxime groups
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.